Semax and Neuroprotection Research: A Review of the Evidence
Semax has been studied for neuroprotective properties in various preclinical models. Here’s a review of what published research shows about Semax’s interactions…
Research Blog
Semax has been studied for neuroprotective properties in various preclinical models. Here’s a review of what published research shows about Semax’s interactions…
Semax has been investigated for its modulation of dopaminergic pathways in preclinical models. Here’s what dopamine does, how Semax interacts with it,…
Semax is a synthetic analog of the ACTH(4-10) fragment with added amino acids for stability. Here’s how this hormone fragment became one…
Selank has been studied in cognitive function research, particularly in preclinical models examining memory and learning pathways. Here’s what published data shows…
A heptapeptide is a peptide made of exactly seven amino acids. Here’s why this size matters, what makes heptapeptides like Selank and…
Both Selank and Semax were developed at the Institute of Molecular Genetics in Moscow. Here’s the story of how Russian researchers created…
Selank has been studied for its effect on BDNF (brain-derived neurotrophic factor) levels in preclinical research. Here’s what BDNF does and what…
Selank has been investigated for its modulation of the GABAergic system in preclinical models. Here’s a plain-English overview of what GABA is…
Selank was developed from tuftsin, a naturally occurring tetrapeptide derived from immunoglobulin G. Here’s how tuftsin became Selank and what that means…
Peptide research in 2026 spans triple agonists, mitochondrial peptides, copper peptides, combination approaches, and rising quality standards. Here’s a data-backed roundup of…